Jacques DJIAN - Vice-President Exploratory Development and Translational Medicine
	Dr. Djian comes to NicOx with 20 years of experience in the pharmaceutical industry through three major pharmaceutical companies.  He was previously the Executive Director and Senior Scientific Consultant for Cardiovascular and Metabolic Disease issues at Novartis in Basel (Switzerland). He has successfully participated to the development of several cardiovascular drugs such as Rasilez® (aliskiren), Diovan® (valsartan) and Exforge® (amlodipine). Dr. Djian has also worked for Wyeth Research as Global Senior Director of the Cardiovascular Area. At Sanofi, he worked as Scientific Director of Clinical Development and successfully participated in the development of the antihypertensive drug Aprovel® (irbesartan) and the anti-platelet agent Plavix® (clopidogrel). Jacques Djian is a Medical Doctor and cardiologist and graduated from the University of Paris. He has also been a practicing cardiologist at Saint-Joseph Hospital in Paris. Dr. Djian is Member of: the French Society of Cardiology, the European Society of Cardiology, the Society of Clinical Pharmacology and Therapeutics, the American Society of Hypertension, the American Society for the Advancement of Science. His academic career combined medical practice, university/hospital teaching, and clinical research. During his hospital career, he was consultant for clinical development for different pharmaceutical companies.
	>> return to list